Business - News | MDDI Online

Admedus Turns Attention to TAVR Program

The Brisbane, Australia-based company is selling the distribution rights to its CardioCel and VascuCel businesses to LeMaitre Vascular so it can concentrate on its transcatheter aortic valve replacement offerings.

Sky Medical Technology Nabs FDA Clearance for VTE Device

The Daresbury, England-based company’s geko works by gently stimulating the common peroneal nerve and activating the calf and foot muscle pumps, resulting in increased blood flow in the deep veins of the calf.

Medtech in a Minute: A Supreme Court Rejection, a Brewing Market Battle, and New Data

Pressed for time? Here's the medtech news you need most, in one minute or less.

Penumbra Looks to Bolster Indigo Through CHEETAH

The Alameda, CA-based company said CHEETAH is a post-market study for the Indigo System with CAT RX Aspiration Catheter.

Dexcom Goes Pro With Latest Nod for CGM System

The San Diego-based company continues to shape its CGM portfolio as it faces off against some stiff competition in the market.

Medtronic and Axonics Go Toe-to-Toe in Fast-Growing Sacral Neuromodulation Market

Medtronic dropped a big announcement this week related to its InterStim Micro Neurostimulator almost exactly a month after Axonics won FDA approval for the first rechargeable sacral neuromodulation device.

Forest Devices Is Crushing It This Year

A startup developing the first portable stroke screening device won the MedTech Innovator 2019 Showcase at The MedTech Conference in Boston, MA.

Investors’ Faith in Endotronix Continues with Expanded D Round

The Lisle, IL-based company initially brought in $45 million in a series D round last year – but expanded the financing and raised an additional $35 million. Endotronix will use proceeds from the round for a more robust clinical trial to nab FDA approval and National Coverage Determination for the Cordella Pulmonary Artery Sensor.

AngioDynamics Has Laser Focus on PAD with New Acquisition

The Latham, NY-based company is set to acquire Eximo Medical for about $46 million in up-front consideration with the possibility of up to $20 million in milestones. Eximo’s laser technology has been cleared by FDA for use in the treatment of Peripheral Artery Disease.

Lantheus Takes a Dive into Pharma with Proposed Acquisition

The North Billerica, MA-based company is set to acquire Progenics Pharmaceuticals, an oncology firm developing innovative medicines and artificial intelligence to find, fight and follow cancer. It is an all-stock transaction set to close in 1Q20.

W.L. Gore’s Cardioform ASD Occluder Obtains CE Mark

The Flagstaff, AZ-based company brings the Cardioform ASD Occluder to Europe a few months after the device received approval in the U.S.

LivaNova Enrolls 1st Patient in RECOVER Depression Treatment Study

The London-based company’s VNS Therapy System, Symmetry, is indicated for the adjunctive long-term treatment of chronic or recurrent depression for patients 18-years of age or older who are experiencing a major depressive episode and have not had an adequate response to four or more adequate antidepressant treatments.

Tales from TCT 2019: Ancora’s Heart Felt Data

During the 31st annual Transcatheter Cardiovascular Therapeutics scientific symposium, Santa Clara, CA-based Ancora presented interim study results from systolic heart failure patients treated with AccuCinch, a percutaneous therapy designed to improve left ventricular function.

This Is the Strongest Pipeline in Medtronic’s History

Medtronic CEO Omar Ishrak has been heard many times this year saying that the company is enjoying the strongest product pipeline in its history. Here's why.

The Moment We've All Been Waiting For: Medtronic's Surgical Robot Unveiled

Medtronic introduced its surgical robotics platform Tuesday along with a real-time demonstration of a cadaver surgical procedure using the robot, plus a surgeon panel discussion.

Qmed Search Form

Business - News